title banner

OR in the News

OR in the News (selected articles)

Jentzer JC, Bhat AG, Patlolla SH, Sinha SS, Miller PE, Lawler PR, van Diepen S, Khanna AK, Zhao DX, Vallabhajosyula S: Concomitant Sepsis Diagnoses in Acute Myocardial Infarction-Cardiogenic Shock: 15-Year National Temporal Trends, Management, and Outcomes. Crit Care Explor 2022; 4: e0637

September 19, 2022

OBJECTIVES:
Mixed cardiogenic-septic shock is common and associated with high mortality. There are limited contemporary data on concomitant sepsis in acute myocardial infarction complicated by cardiogenic shock (AMI-CS).
DESIGN:
Observational study.
SETTING:
Twenty percent stratified sample of all community hospitals (2000–2014) in the United States.
PARTICIPANTS:
Adults (> 18 yr) with AMI-CS with and without concomitant sepsis.
INTERVENTIONS:
None.
MEASUREMENTS AND MAIN RESULTS:
Outcomes of interest included inhospital mortality, development of noncardiac organ failure, complications, utili- zation of guideline-directed procedures, length of stay, and hospitalization costs. Over 15 years, 444,253 AMI-CS admissions were identified, of which 27,057 (6%) included sepsis. The sepsis cohort had more comorbidities and had higher rates of noncardiac multiple organ failure (92% vs 69%) (all p < 0.001). In 2014, compared with 2000, the prevalence of sepsis increased from 0.5% versus 11.5% with an adjusted odds ratio (aOR) 11.71 (95% CI, 9.7–14.0) in ST-segment el- evation myocardial infarction and 24.6 (CI, 16.4–36.7) (all p < 0.001) in non-ST segment elevation myocardial infarction. The sepsis cohort received fewer cardiac interventions (coronary angiography [65% vs 68%], percutaneous coronary in- tervention [43% vs 48%]) and had greater use of mechanical circulatory support (48% vs 45%) and noncardiac support (invasive mechanical ventilation [65% vs 41%] and acute hemodialysis [12% vs 3%]) (p < 0.001). The sepsis cohort had higher inhospital mortality (44.3% vs 38.1%; aOR, 1.21; 95% CI, 1.18–1.25; p < 0.001), longer length of stay (14.0 d [7–24 d] vs 7.0 d [3–12 d]), greater hospitalization costs (×1,000 U.S. dollars) ($176.0 [$85–$331] vs $77.0 [$36– $147]), fewer discharges to home (22% vs 44%) and more discharges to skilled nursing facilities (51% vs 28%) (all p < 0.001). CONCLUSIONS:
In AMI-CS, concomitant sepsis is associated with higher mor- tality and morbidity highlighting the need for early recognition and integrated man- agement of mixed shock.

KEY WORDS:
acute myocardial infarction; cardiogenic shock; circulatory shock; critical care cardiology; sepsis